8 articles · 20 / page
Machine learning is transforming medical devices but faces challenges like shortcut learning and automation bias. Edge AI and evolving regulation aim to balance innovation with safety.
Philips recovered €186 million in U.S. tariff refunds during Q2 2025, while grappling with cost inflation, China headwinds, and currency effects. Strong demand in North America and Europe and emerging opportunities in India were highlighted.
J.P. Morgan reports show biopharma and medtech investment remained strong in H1 2026, with licensing, M&A, venture funding, and IPOs all showing resilience, though investors favored later-stage assets.
Abbott begins a 1,000-patient postmarket study of its TriClip tricuspid repair device, gathering real-world safety and efficacy data ahead of anticipated U.S. competition from Edwards Lifesciences.
ABILITY NeuroTech has announced the first-in-human procedure for its brain-computer interface, capturing neural data during brain tumor surgery at TUM University Hospital.
Boston Scientific slashed its 2026 sales and EPS forecasts for the second straight quarter, citing competitive pressure in pulsed field ablation and declining standalone Watchman procedures.
Dexcom buys Nutrisense and updates Stelo app with AI; Insulet lowers Omnipod 5 target to 100 mg/dL; Beta Bionics shares real-world iLet HbA1c data.
The 2026 Fortune Global 500 includes 25 healthcare companies. Eli Lilly rose 112 spots to 224th, and McKesson entered the top 10 for the first time.
Open language-specific specialty feeds and department pages.